Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
|tissues=Blood cells, Lymphocyte, Platelet | |tissues=Blood cells, Lymphocyte, Platelet | ||
|preparations=Permeabilized cells, Permeabilized tissue | |preparations=Permeabilized cells, Permeabilized tissue | ||
|couplingstates=OXPHOS, | |couplingstates=OXPHOS, ET | ||
|pathways=F, N, S, NS, ROX | |pathways=F, N, S, NS, ROX | ||
|additional=Palmitoylcarnitine | |additional=Palmitoylcarnitine | ||
}} | }} | ||
Revision as of 17:21, 9 November 2017
| Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum |
Link: O2k-Network Discussion Forum
Chou Cheng-Hsien (2015)
Event: Fatty Acid Oxidation O2k-Network Discussion Forum
Protocol: final concentration of digitonin in chamber is 10Ξg/ml cell number in chamber is 2 millions cell/ml, cell type PBMC, Malate (2mM), Palmitoyl-DLcarnitine-HCl (20ΞM), ADP (2.5mM), pyruvate (5mM), glutamate (10mM), succinate (10mM), rotenone (0.1ΞM), malonic acid(5mM), myxothiazol (0.5ΞM), antimycin A (2.5ΞM), TMPD (0.5mM), azide (100mM)
âĒ Keywords: PBMC
Labels:
Tissue;cell: Blood cells, Lymphocyte, Platelet Preparation: Permeabilized cells, Permeabilized tissue
Coupling state: OXPHOS, ET
Pathway: F, N, S, NS, ROX
Palmitoylcarnitine
